Synapse - Works

Results (115783)

P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)

Meeting Abstract

Zebic, D.; Stockler, M. R.; Martin, A.; Pashankar, F.; Tran, B.; Mazhar, D.; Huddart, R.; Wheater, M.; Walpole, E.; Dunwoodie, E.; more...
Asia-Pacific Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Outcomes of allogeneic HCT in patients with Hodgkin lymphoma in the era of checkpoint inhibitors: A joint CIBMTR and EBMT analysis

Meeting Abstract

Perales, M. A.; Awan, F.; Boumendil, A.; Chen, S.; Bazarbachi, A.; Finel, H.; Glass, B.; Herrera, A. F.; Kharfan-Dabaja, M.; Martinez, C.; more...
Bone Marrow Transplantation (2022)

Fulltext@MSK | Save

Prediction of non-relapse mortality in patients with AML and all receiving alloSCT in first CR with post-transplantation cyclophosphamide-based GVHD prophylaxis

Meeting Abstract

Hermans, S. J. F.; Versluis, J.; Labopin, M.; Giebel, S.; van Norden, Y.; Kulagin, A.; Blaise, D.; Díez Martin, J. L.; Meijer, E.; Rovira, M.; more...
Bone Marrow Transplantation (2022)

Fulltext@MSK | Save

Outcomes of autologous hematopoietic cell transplantation (AHCT) in elderly patients with diffuse large B cell lymphoma (DLBCL)

Meeting Abstract

Munshi, P.; Ahn, K.; Kharfan-Dabaja, M.; Herrera, A.; Sauter, C.; Hamadani, M.
Bone Marrow Transplantation (2022)

Fulltext@MSK | Save

Characterization and management of adverse reactions (ARs) in patients with advanced renal cell carcinoma (aRCC) receiving lenvatinib plus pembrolizumab (CLEAR study)

Meeting Abstract

Motzer, R.; George, S.; Merchan, J. R.; Hutson, T. E.; Song, X.; Perini, R. F.; Xie, R.; Bapat, U.; Ebaid, B.; Puente, J.
Asia-Pacific Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Updated efficacy of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in patients with advanced renal cell carcinoma (aRCC) in the CLEAR study

Meeting Abstract

Porta, C. G.; Eto, M.; Motzer, R. J.; De Giorgi, U.; Buchler, T.; Basappa, N. S.; Vidal, M. J.; Tjulandin, S.; Park, S. H.; Melichar, B.; more...
Asia-Pacific Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C

Meeting Abstract

Itchins, M.; Thomas, M.; Garassino, M.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E.; Mazieres, J.; Cortot, A.; more...
Asia-Pacific Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) for the treatment of resectable locally advanced (LA) head and neck squamous cell carcinoma (HNSCC): Phase 3 KEYNOTE-689

Meeting Abstract

Klochikhin, A.; Haddad, R. I.; Meirovitz, A.; Safina, S.; Brana, I.; Le Tourneau, C.; Uppaluri, R.; Lee, N. Y.; Cohen, E. E. W.; Chernock, R.; more...
Asia-Pacific Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Inducible transgenic cerebral organoids model oncogene dependence in pediatric tumorigenesis

Meeting Abstract

Graham, M. S.; Codega, P.; Campos, C.; Rosenblum, M. K.; Antonescu, C. R.; Nandakumar, S.; Benhamida, J. K.; Bale, T. A.; von Deimling, A.; Socci, N. D.; more...
Annals of Neurology (2022)

Fulltext@MSK | Save

Resistant starch diet improves distinct gut microbiota structures in patients with systemic lupus erythematosus and antiphospholipid syndrome

Meeting Abstract

Pereira, M.; Kulyk, I.; Redanz, S.; Ruff, W. E.; Greiling, T. M.; Dehner, C.; Pagovich, O.; Zegarra Ruiz, D.; Aguiar, C.; Erkan, D.; more...
Annals of the Rheumatic Diseases (2022)

Fulltext@MSK | Save